This company has shut down. Better Therapeutics is no longer operating — its last tracked round was a Post-IPO Equity in 2024.
Explore the Startup GraveyardBetter Therapeutics develops prescription software for treating cardiometabolic diseases.
Better Therapeutics has raised $250K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2024.
Better Therapeutics's investors include Hercules Capital, Farallon Capital Management, Sectoral Asset Management, Monashee Investment Management, RS Investments.
Better Therapeutics is headquartered in San Francisco, United States.
Better Therapeutics develops prescription software for treating cardiometabolic diseases.
Better Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Better Therapeutics — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/better-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Better Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/better-therapeutics
{{cite web |title=Better Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/better-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated